Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Authors
Keywords
Hepatitis C, Mental disorders, Psychotropic drugs, Boceprevir, Telaprevir
Journal
BMC GASTROENTEROLOGY
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-05-15
DOI
10.1186/1471-230x-13-86
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Managing Depression during Hepatitis C Treatment
- (2017) Sanjeev Sockalingam et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Escitalopram for the Prevention of Peginterferon-α2a–Associated Depression in Hepatitis C Virus–Infected Patients Without Previous Psychiatric Disease
- (2013) Martin Schaefer et al. ANNALS OF INTERNAL MEDICINE
- A Comparison of Depression Screening Instruments in Hepatitis C and the Impact of Depression on Somatic Symptoms
- (2013) Sanjeev Sockalingam et al. PSYCHOSOMATICS
- QT interval and antidepressant use: a cross sectional study of electronic health records
- (2013) V. M. Castro et al. BMJ-British Medical Journal
- Effect of Telaprevir on the Pharmacokinetics of Buprenorphine in Volunteers on Stable Buprenorphine/Naloxone Maintenance Therapy
- (2012) Xia Luo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters
- (2012) Annett Kunze et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
- (2012) Ellen G. J. Hulskotte et al. CLINICAL INFECTIOUS DISEASES
- Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia
- (2012) Anto P. Rajkumar et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Symptomatic Treatment of Interferon-α–Induced Depression in Hepatitis C
- (2012) Sara Baraldi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
- (2012) Martin Schaefer et al. JOURNAL OF HEPATOLOGY
- Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
- (2012) Brett A. English et al. Current Psychiatry Reports
- Effect of Telaprevir on the Pharmacokinetics of Midazolam and Digoxin
- (2011) Varun Garg et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylactic Antidepressant Treatment in Patients With Hepatitis C on Antiviral Therapy: A Double-Blind, Placebo-Controlled Trial
- (2011) Benjamin J. Morasco et al. PSYCHOSOMATICS
- Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study
- (2010) Catia Marzolini et al. ANTIVIRAL THERAPY
- Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support
- (2010) Jason Grebely et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin
- (2010) Sergio Neri et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update
- (2010) S. Sockalingam et al. JOURNAL OF VIRAL HEPATITIS
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- (2010) Paul Y Kwo et al. LANCET
- Determining rates of hepatitis C in a clozapine treated cohort
- (2010) Sanjeev Sockalingam et al. SCHIZOPHRENIA RESEARCH
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
- (2009) Lakshmi N Yatham et al. BIPOLAR DISORDERS
- Variation in glucuronidation of lamotrigine in human liver microsomes
- (2009) U. A. Argikar et al. XENOBIOTICA
- Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders
- (2008) Annette M Matthews et al. BIPOLAR DISORDERS
- An Update on Clinical Drug Interactions with the Herbal Antidepressant St. Johns wort
- (2008) Shu-Feng Zhou et al. CURRENT DRUG METABOLISM
- Treatment of Hepatitis C With Interferon-α and Ribavirine in a Patient With Long-Term Clozapine Treatment
- (2008) Timo Liukkonen et al. PSYCHOSOMATICS
- The Effect of Pegylated Interferon-α2b and Ribavirin on Posttraumatic Stress Disorder Symptoms
- (2008) Eric Dieperink et al. PSYCHOSOMATICS
- Antiviral Therapy Completion and Response Rates Among Hepatitis C Patients With and Without Schizophrenia
- (2008) M. Huckans et al. SCHIZOPHRENIA BULLETIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now